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Kazuhide Ozaki1 and Jun Iwata3Abstract
We report herein a 41-year-old female with a tubo-ovarian abscess (TOA), which microbial cultures showed to
contain extended-spectrum beta-lactamase (ESBL)-producing E. coli, a causative agent of community-acquired
infection. The patient initially presented with acute abdominal pain and back pain. Pelvic computed tomography
and transvaginal ultrasonography revealed multiple cystic lesions in the bilateral ovaries that suggested TOA. An
emergency laparotomy was therefore performed due to the potential for life-threatening septic shock from the
TOA-associated pelvic inflammatory disease. Microbial cultures of postoperative fluid discharge from the placed
intra-abdominal catheter, vaginal secretions, urine, blood, and feces detected ESBL-producing E.coli. In summary,
we successfully performed emergency surgery for life-threatening septic TOA caused by ESBL-producing E. coli
infection.
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A tubo-ovarian abscess (TOA) can develop in repro-
ductive age women with pelvic inflammatory disease
(PID). The cause of TOA is mostly ascending infection
through the uterus (mainly sexually transmitted dis-
eases) due to Neisseria gonorrhoeae, Chlamydia, Escher-
ichia coli (E. coli), and/or endogenous bacteria of the
vagina and cervix [1, 2]. The management of TOA is a
fundamentally conservative treatment with systemic
broad-spectrum antibiotics. However, a TOA can have
serious and potentially life-threatening consequences
when there is a risk of abscess rupture. In such cases,
antibiotic therapy is not sufficient for treating the TOA,
and surgical drainage must be performed [3–6].
In this case report of a patient with TOA, surgery was
indicated after the initial diagnosis due to the immediate
threat of clinically dangerous septic shock. Although the* Correspondence: teppei.1090@gmail.com
1Department of Gastroenterological Surgery, Kochi Health Sciences Center,
2125-1 Ike, Kochi-City, Kochi 781-8555, Japan
Full list of author information is available at the end of the article
© 2015 Tokumaru et al. Open Access This art
International License (http://creativecommons.o
reproduction in any medium, provided you giv
the Creative Commons license, and indicate ifabscesses were not ruptured, infections to the vagina,
uterus, and bilateral ovaries by extended-spectrum beta-
lactamase (ESBL)-producing E. coli had the potential to
induce septic shock and disseminated intravascular co-
agulation, both of which can be life-threatening condi-
tions. ESBL-producing bacteria infect individuals with
impaired immunity, have resistance to many antibiotics,
and can cause nosocomial infection [7–12]. To our
knowledge, this is the first reported case of a patient
with TOA caused by ESBL-producing E. coli. and treated
with emergency surgery.
Case presentation
A 41-year-old woman presenting with acute abdominal
and back pain was admitted into a neighboring hospital.
She was initially diagnosed with a urinary tract infection
and received systemic antibiotic therapy for 2 days. She
complained of worsening abdominal pain and high fever,
suggesting PID due to bacterial infection into the bilat-
eral ovaries, and was subsequently referred to our hos-
pital. She was previously healthy with no history oficle is distributed under the terms of the Creative Commons Attribution 4.0
rg/licenses/by/4.0/), which permits unrestricted use, distribution, and
e appropriate credit to the original author(s) and the source, provide a link to
changes were made.
Fig. 1 Abdominal computed tomography revealed thick-walled
multilocular cystic lesions at the bilateral ovaries (white arrowheads)
Fig. 2 Transvaginal sonography revealed cystic lesions with septum
at the bilateral ovary
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or overseas travel.
Physical examination revealed a body temperature of 40
degrees, mild abdominal pain, and markedly anemic con-
junctiva. Her abdomen was soft, but showed mild tender-
ness and rebound pain. Hematological and biochemical
testing showed a red blood cell count of 280 × 104/uL
(normal range, 370–490 × 104/uL), hematocrit of 22.5 %
(normal range, 34–49 %), hemoglobin (Hb) level of 7.3 g/dL
(normal range, 11.2–15.7 g/dL), white blood cell count of
16,500/uL, platelet count of 18,000/uL, C-reactive protein
level of 18.0 mg/dL, aspartate transaminase (AST) of 146
IU/L (normal range, 8–38 IU/L), alanine transaminase
(ALT) of 79 IU/L (normal range, 4–44 IU/L), alkaline
phosphatase (ALP) of 563 IU/L (normal range, 115–359
IU/L), lactate dehydrogenase (LD) of 899 IU/L (normal
range, 106–211 IU/L); total protein concentration of
4.6 g/dL (normal range, 6.7–8.3 g/dL), albumin levels
of 2.0 g/dL (normal range, 3.8–5.3 g/dL), cholinesterase
concentration of 104 IU/L (normal range, 229–521 IU/L),
creatinine concentration of 3.1 mg/dL (normal range, 0.4–
0.8 mg/dL), prothrombin time of 44.1 % (normal range,
77.0–104.0 %), activated partial thromboplastin time, 47.7 s
(normal range, 20.0 to 40.0 s), fibrin/fibrinogen degradation
products at 239.4 ug/mL (normal range, 0.0–10.0 ug/mL),
D-dimer levels of 75.1 ug/mL (normal range, 0.0–1.0
ug/mL), antithrombin 3 activity of 53 % (normal range,
81–123 %), base excesses of −13.0 mmol/L (normal
range, −3.0–3.0 mmol/L), and lactate concentration of 12.9
mmol/L (normal range, 0.5–2.0 mmol/L). Other laboratory
tests, including tumor markers (carcinoembryonic antigen,
carbohydrate 19–9, and carbohydrate antigen 125) and viral
status for hepatitis B status and C status, were normal. Ab-
dominal computed tomography (CT) revealed thick-walled
multilocular cystic lesions in the bilateral ovaries, and no
ascites in the pelvis (Fig. 1). TOA was strongly suspected,
and the patient underwent transvaginal ultrasonography,
which demonstrated an 11.1 × 7.9 cm left ovarian cystic
mass with low echogenicity, and a 6.3 × 4.4 cm right ovar-
ian mass with a similar echo-texture (Fig. 2). For further
definitive diagnosis, ultrasound-guided puncture was con-
ducted in the cystic mass and revealed a purulent content.
Together, the clinical presentation and imaging findings
provided a diagnosis of TOA. An emergency laparotomy
was performed based on the clinical diagnosis of septic
shock and already completed DIC due to the TOA.
The gross examination during surgery showed inflam-
mation around the bilateral ovaries that was so marked
that it prevented identification of individual organs. The
bilateral ovaries and uterus were firm to palpate; how-
ever, the vagina in the pelvic cavity was relatively soft on
palpitation. The inflammatory lesions including the ovar-
ies and the uterus containing a uterine fibroid were
resected to control oozing hemorrhage from the pelviccavity because the patient showed evidence of DIC. Dur-
ing this procedure, the cystic component was partially
damaged and discharged a small amount of purulent
fluid, which subsequent cultures showed to contain
ESBL-producing E.coli. Resected specimens of the bilateral
ovaries showed marked swelling and thick-walled multilo-
cular cystic lesions with intraluminal abscesses (Fig. 3).
Microscopic examination of the resected specimen revealed
Fig. 3 Resected specimen of ovary, showing marked swelling of the bilateral ovaries with intraluminal abscess. Pathological examination revealed
the presence of ectopic endometriosis around the ovary (white arrowheads)
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cavity (Fig. 4). No cell types showed atypical mitotic images
or pleomorphisms.
Postoperative microbial cultures of the fluid discharge
from the placed intra-abdominal catheter, vaginal secre-
tions, urine, blood, and feces detected ESBL-producing
E.coli. The patient suffered further abscess formation
due to infection of the postoperative hematoma in the pel-
vic cavity, and underwent a repeat laparotomy with ab-
dominal drainage for diffuse peritonitis 12 days after the
initial surgery. She subsequently suffered intra-abdominal
septic complications, and underwent ultrasound-guided
percutaneous drainage on the 27th postoperative day.
After the drainage, she made a favorable recovery and was
discharged from our hospital 72 days after the first emer-
gency surgery.
Discussion
TOA is most frequently induced by ascending infection
through the uterus due to Neisseria, gonorrhoeae, Chla-
mydia, E. coli, or indigenous bacteria of the vagina and
cervix, and it usually follows PID [1, 2]. Herein, we
present the first reported case of a patient with TOA
caused by ESBL-producing E. coli.
ESBL-producing bacteria is well known as one of the
multiple-antibiotic-resistant bacterium identified by Ger-
man Knothe in 1983 [13]. Our case had no comorbidity,
including diabetes mellitus, respiratory disease, ischemic
heart disease, immune-deficiency disease, and had never
been hospitalized following birth. Thus, we consideredthis case to be a community-acquired infection. Most in-
fections due to ESBL-producing bacteria remain hospital-
acquired and are even more common among long-term
hospitalized and immunocompromised patients [8]. Re-
cently, however, the incidence of community-acquired in-
fection by ESBL-producing bacteria has gradually
increased in Western countries, although it remains rare
in Japan, and the increasing numbers reported have been
attributed to advances in diagnostic techniques and equip-
ments [12, 14, 15]. In the recent years, it has been re-
ported that the incidence of colonization induced by
community-acquired ESBL-producing bacteria from urine
and/or feces has been increased, even with patients with
no comorbidities in Japan as the West. Therefore, the
current study suggested that physicians should pay atten-
tion to the community-acquired infection of ESBL-
producing bacteria which might have been increased in
the future [14, 16, 17].
Treatment of TOA is important to avoid complica-
tions such as life-threatening abscess rupture and sepsis,
and to preserve fertility, so early detection and treatment
of TOA can prevent such adverse outcomes. However, the
peculiar clinical signs of TOA are absent, such as lower
abdominal tenderness, abnormal vaginal or cervical dis-
charge, fever, abnormal vaginal bleeding, dyspareunia, cer-
vical motion tenderness, and adnexal tenderness [18, 19].
Furthermore, it was also very difficult to detect clinically
TOA according to laboratory investigations like following;
findings, presence of excess leucocytes, and/or C-reactive
protein [19]. The differential diagnosis for TOA includes a
Fig. 4 a HE stain ×10. The ovary showed a high degree of neutrophil
infiltration with abscess formation. b HE stain ×100. High-power
magnification showed a cluster of neutrophils in the ovary
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intestinal inflammation, urinary tract infection. Therefore
the diagnosis of TOA based on clinical criteria alone at
the early stage is difficult and inaccurate [18, 19]. In the
present case, the diagnosis of potential TOA was sug-
gested strongly by subsequent transvaginal ultrasound.
Interestingly, this patient with insufficiency of intravenous
antibiotics treatment ran a fatal course due to subsequent
septic complication for TOA in only two days. In general,
ruptured TOA can rapidly become critical for the patient,
whereas unruptured TOA commonly progresses slowly
[19, 20]. A rapid onset of endotoxin shock and DIC is
commonly inferred with Gram-negative E. coli, especially
in this case with detection of the multiple-antibiotic-
resistant ESBL-producing bacteria, which produces endo-
toxin and generally enter the bloodstream and peritoneal
pelvic cavity, causing high fever and acute lower abdom-
inal pain.
Therapeutically, when conservative management with
antibiotics is ineffective, surgical management is stronglyrecommended for TOA [4, 7]. As surgical management,
surgical drainage, salpingo-oophorectomy, and abdom-
inal hysterectomy in combination with antibiotics is
generally performed in women with TOA [21–23], with
the aim of being minimally invasive and as conservative
as possible [24–27]. In our case, because the TOA
could have developed under septic conditions and thus
rapidly induce the critical condition of DIC, we imme-
diately proceeded with surgical treatment by salpingo-
oophorectomy and hysterectomy.
In conclusion, we successfully performed emergency
surgery for life-threatening septic TOA caused by ESBL-
producing E. coli, which was not controlled with conser-
vative antibiotic treatment. To ensure the best manage-
ment of such cases, reporting of cases with similar
pathological and bacteriological findings is warranted.
Conclusions
Aggressive surgery is a valid choice for treating TOA in
specific life-threatening situations.
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